Neonatal abstinence syndrome: advances in diagnosis and treatment

EM Wachman, DM Schiff, M Silverstein - Jama, 2018 - jamanetwork.com
Importance Neonatal abstinence syndrome, which occurs as a result of in utero opioid
exposure, affects between 6.0 and 20 newborns per 1000 live US births. There is substantial …
被引用次数：203 相关文章

Neonatal Abstinence Syndrome: Advances in Diagnosis and Treatment

EM Wachman, DM Schiff… - Obstetric Anesthesia …, 2019 - ingentaconnect.com
(JAMA. 2018; 319 (13): 1362–1374) The signs and symptoms of withdrawal that infants
develop after in utero exposure to opioids is referred to as neonatal abstinence syndrome …

Neonatal Abstinence Syndrome: Advances in Diagnosis and Treatment.

EM Wachman, DM Schiff, M Silverstein - JAMA, 2018 - europepmc.org
Neonatal Abstinence Syndrome: Advances in Diagnosis and Treatment. - Abstract - Europe
PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers …

Neonatal Abstinence Syndrome: Advances in Diagnosis and Treatment

EM Wachman, DM Schiff, M Silverstein - JAMA, 2018 - pubmed.ncbi.nlm.nih.gov
Importance Neonatal abstinence syndrome, which occurs as a result of in utero opioid
exposure, affects between 6.0 and 20 newborns per 1000 live US births. There is substantial …
[PDF] ilpqc.org

[PDF][PDF] Neonatal Abstinence Syndrome Advances in Diagnosis and Treatment

EM Wachman, DM Schiff, M Silverstein - JAMA, 2018 - ilpqc.org
OBJECTIVE To summarize key studies examining the diagnosis and management (both
pharmacologic and nonpharmacologic) of neonatal abstinence syndrome published during …

Neonatal Abstinence Syndrome: Advances in Diagnosis and Treatment

EM Wachman, DM Schiff… - Obstetric Anesthesia …, 2019 - journals.lww.com
Downloaded from by BhDMf5ePHKbH4TTImqenVA+ lpWIIBvonhQl60Etgtdnn9T1vLQWJq/+
R2O4Kjt58 on 11/12/2023 exposed children. Infants with severe withdrawal symptoms …